MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
The Long-Term Benefit of CTO Recanalization
Using CTO PCI to improve long-term clinical outcomes.
By Barbara Anna Danek, MD, and Emmanouil S. Brilakis, MD, PhD
Mechanical Circulatory Support Management
Options beyond the cath lab.
By Mohamed Omer, MD; Ilias Nikolakopoulos, MD; Evangelia Vemmou, MD; Iosif Xenogiannis, MD; Michael Megaly, MD; and Emmanouil S. Brilakis, MD, PhD
Management of Balloon Undilatable CTOs
An appraisal of the available and potential device and technique options and treatment algorithms used to manage balloon undilatable lesions.
By Peter Tajti, MD; Iosif Xenogiannis, MD; Hatem Najar, MD; and Emmanouil S. Brilakis, MD, PhD
Sponsored by Abiomed, Inc.
Case Report: Impella 2.5™ Support During Left Main Coronary Artery Stenting and Transcatheter Occlusion of a Left Internal Mammary Artery Bypass Graft in a Patient With Severe Congestive Heart Failure
By Neeraj Badhey, MD; Subhash Banerjee, MD; and Emmanouil S. Brilakis, MD, PhD
Bypass Graft PCI Shows Higher Adverse Event Rate Compared to Native Artery PCI in Patients With Previous CABG
April 19, 2016—Emmanouil S. Brilakis, MD, et al conducted an investigation of percutaneous coronary intervention (PCI) in native coronary arteries versus bypass grafts in patients with previous coronary artery bypass graft (CABG) surgery. The study was published online ahead of print in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.
Expanding the Possibilities of PCI
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Current Trends in PCI
Asahi Caravel Microcatheter Launched in the United States
June 7, 2016—Asahi Intecc Company, Ltd, recently announced the full launch of the Asahi Caravel microcatheter in the United States, where it is approved for both coronary and peripheral applications.
Review Shows DES Outperform BMS in Treating CTOs
February 9, 2011—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a systematic review of medical evidence has determined that drug-eluting stents (DES) outperform bare-metal stents (BMS) for revascularization of chronic total occlusions (CTOs) of coronary vessels.
Use of the CrossBoss Catheter Studied for PCI of Chronic Total Occlusions
October 31, 2017—Findings from the CrossBoss First trial, which is evaluating the optimal initial strategy for crossing chronic total occlusions (CTOs) during percutaneous coronary intervention (PCI) procedures, were presented at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30 to November 2 in Denver, Colorado.
PCI in Practice and Update on Mechanical Circulatory Support
By Christopher Cook, BSc, MBBS, MRCP, PhD, and M. Chadi Alraies, MD
CSI Announces First Treatments in United States With OrbusNeich Teleport Microcatheter
January 9, 2019—Cardiovascular Systems, Inc. (CSI) announced that the first patients in the United States were treated using the compay's OrbusNeich Teleport microcatheter, which recently received FDA 510(k) clearance.
